Novo Nordisk
Forbes Global 2000 1923 #137 by revenue Denmark Healthcare Drugs & Biotechnology novonordisk-us.com
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products.
Forbes Global 2000's description, shown to identify the company. We rate the name, not the business.
- Evocativity EVOC : red
- New Nordic meaning gives no medicine cue
- Brevity BREV : red
- 11 letters, 4 syllables. Up to seven letters is green, eight at two syllables too; up to ten yellow, eleven or more red.
- Greppability GREP : green
- Found inside 0 other dictionary words.
- Googlability GOOG : green
- Distinctive full institutional pairing
- Pronounceability PRON : green
- Recognizable no-vo nor-disk syllables read clearly
- Spellability SPEL : yellow
- Nordisk versus Nordisc is uncertain by ear
- Verbability VERB : red
- Two-word institution name resists verb use
- Nominology
- 48
- All seven dimensions and .com ownership, weighted as set out on Methodology.
- Fluency
- 60
- Brevity and pronounceability only: the subset with published outcome evidence behind it.
- PG grade
- 3 / 4
- Graham's own four-step ladder.
- Exact .com
- Not owned
- Shape
- phrase
- Length
- 12 chars, 4 syllables
- Distinctiveness
- arbitrary
Rubric version 2026.10.20-1, judged by gpt-6.1-sol (agent).
This scores the name only. See Methodology.
These judged dimensions came from an AI agent working through the judging queue in a chat, on the same rubric the scoring pipeline sends. The agent passed the calibration exam before its work was accepted, and each batch it judged hid two names with known answers as a check. The model is named as the agent reported it.